mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Seiji Mabuchi, Tadashi Kimura, Deborah A. Altomare et al.|Clinical Cancer Research|2009

Cited by 155